The clinical trial of indications for hand foot mouth disease of Reduning in Kangyuan Pharmaceutical Co., Ltd. has not yet achieved results
-
Last Update: 2014-09-11
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
The source said that due to the epidemic nature of HFMD and the combination of drugs and other factors, it is difficult to collect cases At the same time, there are also cases where doctors approve the therapeutic effect of drugs but do not report it Reduning injection is the key product of Kangyuan pharmaceutical industry, accounting for nearly 50% of the company's operating revenue It is worth mentioning that in order to enhance the market competitiveness of products, Kangyuan pharmaceutical has repeatedly improved product quality standards and expanded new indications Reduning is mainly used for the treatment of high fever and slight evil wind chill caused by upper respiratory tract infection (exogenous wind heat syndrome) The product belongs to the recommended drug in the treatment guide of hand, foot and mouth disease issued by the Ministry of health Previously, the company hoped to promote the academic promotion and sales of products by increasing the indications of HFMD.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
